GMHC Treat Issues. 1999 Mar;13(3):1-2. Unique Identifier : AIDSLINE AIDS/20700063
Kasper T
Abstract: Sub-Saharan Africa has been seriously affected by the AIDS epidemic, with infection rates exceeding 30 percent in some areas. Unfortunately, most of the drugs used for treatment in the United States are not available in other countries because of high costs. The high costs can be attributed to the pharmaceutical companies' patents, which are retained for 20 years. The drugs could be manufactured in other countries at a fraction of the cost if a provision that allowed for it were to be included in the Trade-Related Aspects of the Intellectual Property Rights Agreement, part of the World Trade Organization. This provision would give governments the right to circumvent patents in national emergencies, which is called compulsory licensing. Because so few expensive drugs are sold in poor countries, compulsory licensing would not lead to significant profit losses for drug companies.
Copyright © 2000 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .